Written Declaration on Chronic Respiratory Diseases

eaaci news written declaration

Chronic respiratory diseases (including respiratory allergy, asthma and COPD) account for more than 315,000 Europeans dying every year and cost the European economies over EUR 300 billion annually.

EAACI has joined forces with EFA, ERS, ELF, IPCRG, ENSP, PHA Europe, HEAL and EPF and asks Members of European Parliament to take action now by signing the Written Declaration on Chronic Respiratory Diseases (WD 115/2016).


The Written Declaration is a statement, which calls the European Council and the Commission to act for better Prevention, Diagnosis, Care and Rehabilitation in Chronic Respiratory Diseases and more specifically it calls for:

  • Decreasing the economic burden of chronic respiratory diseases on national healthcare systems, and ensuring a high level of protection of citizens’ health;
  • Boosting research on the causes of chronic respiratory diseases and
  • Sharing best practices and studying the possibility of a comprehensive strategy for meeting the challenges posed by chronic respiratory diseases.

The declaration has the possibility of giving further political recognition to chronic respiratory diseases including respiratory allergy and asthma and could help foster coordinated actions on the topic between Member States as well as more fund for research.

To be adopted, the declaration has to be signed by the majority of all Members of European Parliament (376 MEPs out of 751) within 3 months. To realise this objective, we very need your help to incite national MEPs to sign.

What you can do:

Thank you for your support!

Please do not hesitate to contact us should you have any questions.
Last updated 20 April 2017
EAACI's EU liaison office in Brussels acts as the contact point for internal and external EAACI EU Affairs relations.
EAACI – EU Liaison Office
Rue du Luxembourg, 22-24
B-1000 Brussels
Tel : +32 (2)2 761 66 83


As the leading European medical society focusing on allergy, EAACI has a key role to play in the formulation of health and research policies at the European level. EAACI activities focus on improving allergy care, fostering allergy research and help strengthen Allergology as a medical specialty.

By being present in Brussels, EAACI aims to establish allergy ambassadors among EU Parliament members and to have consistent interaction with different EU Institutions, to promote allergy awareness.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback